President and COO of Ligand Pharmaceuticals Inc (30-Year Financial, Insider Trades) Matthew W Foehr (insider trades) sold 7,225 shares of LGND on 02/27/2020 at an average price of $110 a share. The total sale was $794,750.
Ligand Pharmaceuticals Inc is a biopharmaceutical company. Its business model is based upon the concept of acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand Pharmaceuticals Inc has a market cap of $1.82 billion; its shares were traded at around $103.36 with a P/E ratio of 3.52 and P/S ratio of 14.27. Ligand Pharmaceuticals Inc had annual average EBITDA growth of 56.10% over the past five years. GuruFocus has detected 2 severe warning signs with Ligand Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- President and COO Matthew W Foehr sold 7,225 shares of LGND stock on 02/27/2020 at the average price of $110. The price of the stock has decreased by 6.04% since.
- President and COO Matthew W Foehr sold 7,225 shares of LGND stock on 02/14/2020 at the average price of $95.84. The price of the stock has increased by 7.85% since.
For the complete insider trading history of LGND, click here
.
